IL2 and systemic lupus erythematosus: Similarly, high expression of PD‐1 was explored on Tfrs (Figure 3) with dysfunction of suppressing Tfhs proliferation and activation in patients with SLE due to IL‐2 deficiency, which could also be rescued by low‐dose IL‐2 treatment.246